Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)

Completed

Phase 3 Results

Eligibility Criteria

Inclusion Criteria

- Stable coronary artery disease for 3 months or more
- 18 years of age or older with a history of migraine with or without aura
- Must use acceptable contraception throughout the study

Exclusion Criteria

- Pregnant, breast-feeding, or planning to become pregnant during this study
- 50 years of age or older when migraines began
- Other pain syndromes that might interfere with study assessments, uncontrolled psychiatric conditions, dementia, or significant neurological disorders (other than migraine)
- History of gastric, or small intestinal surgery, or has a disease that causes malabsorption